Global PD-L1 Biomarker Testing Market Research Report 2024(Status and Outlook)
Report Overview:
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
The Global PD-L1 Biomarker Testing Market Size was estimated at USD 206.97 million in 2023 and is projected to reach USD 1473.59 million by 2029, exhibiting a CAGR of 38.70% during the forecast period.
This report provides a deep insight into the global PD-L1 Biomarker Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-L1 Biomarker Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-L1 Biomarker Testing market in any manner.
Global PD-L1 Biomarker Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Roche
Market Segmentation (by Type)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-L1 Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PDL1 testing is used to find out if you have a cancer that may benefit from immunotherapy.
The Global PD-L1 Biomarker Testing Market Size was estimated at USD 206.97 million in 2023 and is projected to reach USD 1473.59 million by 2029, exhibiting a CAGR of 38.70% during the forecast period.
This report provides a deep insight into the global PD-L1 Biomarker Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-L1 Biomarker Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-L1 Biomarker Testing market in any manner.
Global PD-L1 Biomarker Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies
Roche
Market Segmentation (by Type)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
Market Segmentation (by Application)
Hospital
Diagnostic Center
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the PD-L1 Biomarker Testing Market
- Overview of the regional outlook of the PD-L1 Biomarker Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD-L1 Biomarker Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of PD-L1 Biomarker Testing
1.2 Key Market Segments
1.2.1 PD-L1 Biomarker Testing Segment by Type
1.2.2 PD-L1 Biomarker Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-L1 BIOMARKER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-L1 Biomarker Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-L1 BIOMARKER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-L1 Biomarker Testing Sales by Manufacturers (2019-2024)
3.2 Global PD-L1 Biomarker Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-L1 Biomarker Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-L1 Biomarker Testing Sales Sites, Area Served, Product Type
3.6 PD-L1 Biomarker Testing Market Competitive Situation and Trends
3.6.1 PD-L1 Biomarker Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-L1 Biomarker Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-L1 BIOMARKER TESTING INDUSTRY CHAIN ANALYSIS
4.1 PD-L1 Biomarker Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-L1 BIOMARKER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-L1 Biomarker Testing Sales Market Share by Type (2019-2024)
6.3 Global PD-L1 Biomarker Testing Market Size Market Share by Type (2019-2024)
6.4 Global PD-L1 Biomarker Testing Price by Type (2019-2024)
7 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-L1 Biomarker Testing Market Sales by Application (2019-2024)
7.3 Global PD-L1 Biomarker Testing Market Size (M USD) by Application (2019-2024)
7.4 Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2019-2024)
8 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY REGION
8.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.2 Global PD-L1 Biomarker Testing Sales Market Share by Region
8.2 North America
8.2.1 North America PD-L1 Biomarker Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-L1 Biomarker Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-L1 Biomarker Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-L1 Biomarker Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-L1 Biomarker Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies PD-L1 Biomarker Testing Basic Information
9.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Overview
9.1.3 Agilent Technologies PD-L1 Biomarker Testing Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies PD-L1 Biomarker Testing SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 Roche
9.2.1 Roche PD-L1 Biomarker Testing Basic Information
9.2.2 Roche PD-L1 Biomarker Testing Product Overview
9.2.3 Roche PD-L1 Biomarker Testing Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche PD-L1 Biomarker Testing SWOT Analysis
9.2.6 Roche Recent Developments
10 PD-L1 BIOMARKER TESTING MARKET FORECAST BY REGION
10.1 Global PD-L1 Biomarker Testing Market Size Forecast
10.2 Global PD-L1 Biomarker Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-L1 Biomarker Testing Market Size Forecast by Country
10.2.3 Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region
10.2.4 South America PD-L1 Biomarker Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-L1 Biomarker Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-L1 Biomarker Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-L1 Biomarker Testing by Type (2025-2030)
11.1.2 Global PD-L1 Biomarker Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-L1 Biomarker Testing by Type (2025-2030)
11.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2025-2030)
11.2.1 Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application
11.2.2 Global PD-L1 Biomarker Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of PD-L1 Biomarker Testing
1.2 Key Market Segments
1.2.1 PD-L1 Biomarker Testing Segment by Type
1.2.2 PD-L1 Biomarker Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-L1 BIOMARKER TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global PD-L1 Biomarker Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global PD-L1 Biomarker Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-L1 BIOMARKER TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global PD-L1 Biomarker Testing Sales by Manufacturers (2019-2024)
3.2 Global PD-L1 Biomarker Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-L1 Biomarker Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers PD-L1 Biomarker Testing Sales Sites, Area Served, Product Type
3.6 PD-L1 Biomarker Testing Market Competitive Situation and Trends
3.6.1 PD-L1 Biomarker Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-L1 Biomarker Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-L1 BIOMARKER TESTING INDUSTRY CHAIN ANALYSIS
4.1 PD-L1 Biomarker Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PD-L1 BIOMARKER TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-L1 Biomarker Testing Sales Market Share by Type (2019-2024)
6.3 Global PD-L1 Biomarker Testing Market Size Market Share by Type (2019-2024)
6.4 Global PD-L1 Biomarker Testing Price by Type (2019-2024)
7 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-L1 Biomarker Testing Market Sales by Application (2019-2024)
7.3 Global PD-L1 Biomarker Testing Market Size (M USD) by Application (2019-2024)
7.4 Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2019-2024)
8 PD-L1 BIOMARKER TESTING MARKET SEGMENTATION BY REGION
8.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.1 Global PD-L1 Biomarker Testing Sales by Region
8.1.2 Global PD-L1 Biomarker Testing Sales Market Share by Region
8.2 North America
8.2.1 North America PD-L1 Biomarker Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-L1 Biomarker Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-L1 Biomarker Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-L1 Biomarker Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-L1 Biomarker Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies
9.1.1 Agilent Technologies PD-L1 Biomarker Testing Basic Information
9.1.2 Agilent Technologies PD-L1 Biomarker Testing Product Overview
9.1.3 Agilent Technologies PD-L1 Biomarker Testing Product Market Performance
9.1.4 Agilent Technologies Business Overview
9.1.5 Agilent Technologies PD-L1 Biomarker Testing SWOT Analysis
9.1.6 Agilent Technologies Recent Developments
9.2 Roche
9.2.1 Roche PD-L1 Biomarker Testing Basic Information
9.2.2 Roche PD-L1 Biomarker Testing Product Overview
9.2.3 Roche PD-L1 Biomarker Testing Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche PD-L1 Biomarker Testing SWOT Analysis
9.2.6 Roche Recent Developments
10 PD-L1 BIOMARKER TESTING MARKET FORECAST BY REGION
10.1 Global PD-L1 Biomarker Testing Market Size Forecast
10.2 Global PD-L1 Biomarker Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD-L1 Biomarker Testing Market Size Forecast by Country
10.2.3 Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region
10.2.4 South America PD-L1 Biomarker Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD-L1 Biomarker Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global PD-L1 Biomarker Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of PD-L1 Biomarker Testing by Type (2025-2030)
11.1.2 Global PD-L1 Biomarker Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of PD-L1 Biomarker Testing by Type (2025-2030)
11.2 Global PD-L1 Biomarker Testing Market Forecast by Application (2025-2030)
11.2.1 Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application
11.2.2 Global PD-L1 Biomarker Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-L1 Biomarker Testing Market Size Comparison by Region (M USD)
Table 5. Global PD-L1 Biomarker Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global PD-L1 Biomarker Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-L1 Biomarker Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2022)
Table 10. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-L1 Biomarker Testing Sales Sites and Area Served
Table 12. Manufacturers PD-L1 Biomarker Testing Product Type
Table 13. Global PD-L1 Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-L1 Biomarker Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-L1 Biomarker Testing Market Challenges
Table 22. Global PD-L1 Biomarker Testing Sales by Type (K Units)
Table 23. Global PD-L1 Biomarker Testing Market Size by Type (M USD)
Table 24. Global PD-L1 Biomarker Testing Sales (K Units) by Type (2019-2024)
Table 25. Global PD-L1 Biomarker Testing Sales Market Share by Type (2019-2024)
Table 26. Global PD-L1 Biomarker Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-L1 Biomarker Testing Market Size Share by Type (2019-2024)
Table 28. Global PD-L1 Biomarker Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global PD-L1 Biomarker Testing Sales (K Units) by Application
Table 30. Global PD-L1 Biomarker Testing Market Size by Application
Table 31. Global PD-L1 Biomarker Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global PD-L1 Biomarker Testing Sales Market Share by Application (2019-2024)
Table 33. Global PD-L1 Biomarker Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-L1 Biomarker Testing Market Share by Application (2019-2024)
Table 35. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-L1 Biomarker Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global PD-L1 Biomarker Testing Sales Market Share by Region (2019-2024)
Table 38. North America PD-L1 Biomarker Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe PD-L1 Biomarker Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific PD-L1 Biomarker Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America PD-L1 Biomarker Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa PD-L1 Biomarker Testing Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies PD-L1 Biomarker Testing Basic Information
Table 44. Agilent Technologies PD-L1 Biomarker Testing Product Overview
Table 45. Agilent Technologies PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies PD-L1 Biomarker Testing SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. Roche PD-L1 Biomarker Testing Basic Information
Table 50. Roche PD-L1 Biomarker Testing Product Overview
Table 51. Roche PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche PD-L1 Biomarker Testing SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Global PD-L1 Biomarker Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 56. Global PD-L1 Biomarker Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America PD-L1 Biomarker Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 58. North America PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe PD-L1 Biomarker Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 60. Europe PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific PD-L1 Biomarker Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America PD-L1 Biomarker Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 64. South America PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa PD-L1 Biomarker Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global PD-L1 Biomarker Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 68. Global PD-L1 Biomarker Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global PD-L1 Biomarker Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 70. Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application (2025-2030)
Table 71. Global PD-L1 Biomarker Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-L1 Biomarker Testing Market Size Comparison by Region (M USD)
Table 5. Global PD-L1 Biomarker Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global PD-L1 Biomarker Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global PD-L1 Biomarker Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2022)
Table 10. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers PD-L1 Biomarker Testing Sales Sites and Area Served
Table 12. Manufacturers PD-L1 Biomarker Testing Product Type
Table 13. Global PD-L1 Biomarker Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-L1 Biomarker Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-L1 Biomarker Testing Market Challenges
Table 22. Global PD-L1 Biomarker Testing Sales by Type (K Units)
Table 23. Global PD-L1 Biomarker Testing Market Size by Type (M USD)
Table 24. Global PD-L1 Biomarker Testing Sales (K Units) by Type (2019-2024)
Table 25. Global PD-L1 Biomarker Testing Sales Market Share by Type (2019-2024)
Table 26. Global PD-L1 Biomarker Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global PD-L1 Biomarker Testing Market Size Share by Type (2019-2024)
Table 28. Global PD-L1 Biomarker Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global PD-L1 Biomarker Testing Sales (K Units) by Application
Table 30. Global PD-L1 Biomarker Testing Market Size by Application
Table 31. Global PD-L1 Biomarker Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global PD-L1 Biomarker Testing Sales Market Share by Application (2019-2024)
Table 33. Global PD-L1 Biomarker Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global PD-L1 Biomarker Testing Market Share by Application (2019-2024)
Table 35. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global PD-L1 Biomarker Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global PD-L1 Biomarker Testing Sales Market Share by Region (2019-2024)
Table 38. North America PD-L1 Biomarker Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe PD-L1 Biomarker Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific PD-L1 Biomarker Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America PD-L1 Biomarker Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa PD-L1 Biomarker Testing Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies PD-L1 Biomarker Testing Basic Information
Table 44. Agilent Technologies PD-L1 Biomarker Testing Product Overview
Table 45. Agilent Technologies PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies Business Overview
Table 47. Agilent Technologies PD-L1 Biomarker Testing SWOT Analysis
Table 48. Agilent Technologies Recent Developments
Table 49. Roche PD-L1 Biomarker Testing Basic Information
Table 50. Roche PD-L1 Biomarker Testing Product Overview
Table 51. Roche PD-L1 Biomarker Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche PD-L1 Biomarker Testing SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Global PD-L1 Biomarker Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 56. Global PD-L1 Biomarker Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 57. North America PD-L1 Biomarker Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 58. North America PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 59. Europe PD-L1 Biomarker Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 60. Europe PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 61. Asia Pacific PD-L1 Biomarker Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 62. Asia Pacific PD-L1 Biomarker Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 63. South America PD-L1 Biomarker Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 64. South America PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 65. Middle East and Africa PD-L1 Biomarker Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 66. Middle East and Africa PD-L1 Biomarker Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 67. Global PD-L1 Biomarker Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 68. Global PD-L1 Biomarker Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 69. Global PD-L1 Biomarker Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 70. Global PD-L1 Biomarker Testing Sales (K Units) Forecast by Application (2025-2030)
Table 71. Global PD-L1 Biomarker Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of PD-L1 Biomarker Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-L1 Biomarker Testing Market Size (M USD), 2019-2030
Figure 5. Global PD-L1 Biomarker Testing Market Size (M USD) (2019-2030)
Figure 6. Global PD-L1 Biomarker Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-L1 Biomarker Testing Market Size by Country (M USD)
Figure 11. PD-L1 Biomarker Testing Sales Share by Manufacturers in 2023
Figure 12. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers in 2023
Figure 13. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-L1 Biomarker Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-L1 Biomarker Testing Market Share by Type
Figure 18. Sales Market Share of PD-L1 Biomarker Testing by Type (2019-2024)
Figure 19. Sales Market Share of PD-L1 Biomarker Testing by Type in 2023
Figure 20. Market Size Share of PD-L1 Biomarker Testing by Type (2019-2024)
Figure 21. Market Size Market Share of PD-L1 Biomarker Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-L1 Biomarker Testing Market Share by Application
Figure 24. Global PD-L1 Biomarker Testing Sales Market Share by Application (2019-2024)
Figure 25. Global PD-L1 Biomarker Testing Sales Market Share by Application in 2023
Figure 26. Global PD-L1 Biomarker Testing Market Share by Application (2019-2024)
Figure 27. Global PD-L1 Biomarker Testing Market Share by Application in 2023
Figure 28. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-L1 Biomarker Testing Sales Market Share by Region (2019-2024)
Figure 30. North America PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America PD-L1 Biomarker Testing Sales Market Share by Country in 2023
Figure 32. U.S. PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada PD-L1 Biomarker Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico PD-L1 Biomarker Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe PD-L1 Biomarker Testing Sales Market Share by Country in 2023
Figure 37. Germany PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific PD-L1 Biomarker Testing Sales Market Share by Region in 2023
Figure 44. China PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 50. South America PD-L1 Biomarker Testing Sales Market Share by Country in 2023
Figure 51. Brazil PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa PD-L1 Biomarker Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global PD-L1 Biomarker Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global PD-L1 Biomarker Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-L1 Biomarker Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-L1 Biomarker Testing Sales Forecast by Application (2025-2030)
Figure 66. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of PD-L1 Biomarker Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-L1 Biomarker Testing Market Size (M USD), 2019-2030
Figure 5. Global PD-L1 Biomarker Testing Market Size (M USD) (2019-2030)
Figure 6. Global PD-L1 Biomarker Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-L1 Biomarker Testing Market Size by Country (M USD)
Figure 11. PD-L1 Biomarker Testing Sales Share by Manufacturers in 2023
Figure 12. Global PD-L1 Biomarker Testing Revenue Share by Manufacturers in 2023
Figure 13. PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-L1 Biomarker Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-L1 Biomarker Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-L1 Biomarker Testing Market Share by Type
Figure 18. Sales Market Share of PD-L1 Biomarker Testing by Type (2019-2024)
Figure 19. Sales Market Share of PD-L1 Biomarker Testing by Type in 2023
Figure 20. Market Size Share of PD-L1 Biomarker Testing by Type (2019-2024)
Figure 21. Market Size Market Share of PD-L1 Biomarker Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-L1 Biomarker Testing Market Share by Application
Figure 24. Global PD-L1 Biomarker Testing Sales Market Share by Application (2019-2024)
Figure 25. Global PD-L1 Biomarker Testing Sales Market Share by Application in 2023
Figure 26. Global PD-L1 Biomarker Testing Market Share by Application (2019-2024)
Figure 27. Global PD-L1 Biomarker Testing Market Share by Application in 2023
Figure 28. Global PD-L1 Biomarker Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global PD-L1 Biomarker Testing Sales Market Share by Region (2019-2024)
Figure 30. North America PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America PD-L1 Biomarker Testing Sales Market Share by Country in 2023
Figure 32. U.S. PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada PD-L1 Biomarker Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico PD-L1 Biomarker Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe PD-L1 Biomarker Testing Sales Market Share by Country in 2023
Figure 37. Germany PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific PD-L1 Biomarker Testing Sales Market Share by Region in 2023
Figure 44. China PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 50. South America PD-L1 Biomarker Testing Sales Market Share by Country in 2023
Figure 51. Brazil PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa PD-L1 Biomarker Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa PD-L1 Biomarker Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa PD-L1 Biomarker Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global PD-L1 Biomarker Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global PD-L1 Biomarker Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global PD-L1 Biomarker Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global PD-L1 Biomarker Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global PD-L1 Biomarker Testing Sales Forecast by Application (2025-2030)
Figure 66. Global PD-L1 Biomarker Testing Market Share Forecast by Application (2025-2030)
